BELLOTTI, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 7.612
AS - Asia 6.087
EU - Europa 4.849
SA - Sud America 763
AF - Africa 158
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.489
Nazione #
US - Stati Uniti d'America 7.456
CN - Cina 3.062
SG - Singapore 1.311
IE - Irlanda 1.113
HK - Hong Kong 684
UA - Ucraina 616
BR - Brasile 581
FI - Finlandia 556
RU - Federazione Russa 508
DE - Germania 497
VN - Vietnam 459
IT - Italia 401
FR - Francia 328
GB - Regno Unito 290
SE - Svezia 271
IN - India 151
CA - Canada 80
ZA - Sudafrica 68
AR - Argentina 62
BD - Bangladesh 59
PL - Polonia 55
MX - Messico 51
TR - Turchia 48
JP - Giappone 44
BE - Belgio 39
IQ - Iraq 38
NL - Olanda 31
ES - Italia 30
ID - Indonesia 30
CO - Colombia 26
VE - Venezuela 26
PK - Pakistan 25
EC - Ecuador 22
MA - Marocco 22
TN - Tunisia 18
UZ - Uzbekistan 18
PH - Filippine 17
SA - Arabia Saudita 17
KE - Kenya 16
CZ - Repubblica Ceca 15
AT - Austria 12
CL - Cile 12
JO - Giordania 12
BO - Bolivia 11
IR - Iran 10
KR - Corea 10
LT - Lituania 10
PE - Perù 10
PY - Paraguay 10
DK - Danimarca 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
HR - Croazia 8
EG - Egitto 7
HU - Ungheria 7
IL - Israele 7
JM - Giamaica 7
KG - Kirghizistan 7
LV - Lettonia 7
MU - Mauritius 7
MY - Malesia 7
AZ - Azerbaigian 6
NZ - Nuova Zelanda 6
OM - Oman 6
RO - Romania 6
AL - Albania 5
CH - Svizzera 5
GR - Grecia 5
PT - Portogallo 5
SN - Senegal 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KW - Kuwait 4
LB - Libano 4
MD - Moldavia 4
NI - Nicaragua 4
NP - Nepal 4
RS - Serbia 4
BG - Bulgaria 3
CR - Costa Rica 3
EE - Estonia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BN - Brunei Darussalam 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
MN - Mongolia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 19.462
Città #
Dublin 1.111
Chandler 1.033
Jacksonville 752
San Jose 690
Singapore 675
Hong Kong 665
Nanjing 665
Ashburn 615
Dallas 567
Beijing 537
Boardman 319
Nanchang 277
Princeton 222
Shenyang 202
Wilmington 200
Hebei 185
Lauterbourg 185
Lawrence 184
Ann Arbor 176
Changsha 174
Los Angeles 169
Helsinki 160
Medford 154
Ho Chi Minh City 146
Jiaxing 135
New York 114
Hanoi 110
Tianjin 106
Munich 104
Buffalo 96
Hangzhou 95
Milan 91
Moscow 89
Shanghai 76
Woodbridge 75
Redondo Beach 71
São Paulo 61
Johannesburg 56
Turku 51
Orem 50
Pavia 46
Verona 42
The Dalles 41
Falls Church 40
Santa Clara 39
Brussels 38
Tokyo 38
Warsaw 38
Chennai 34
Chicago 31
Frankfurt am Main 31
Norwalk 30
Piscataway 30
Toronto 30
Denver 29
Fairfield 26
Montreal 26
Brooklyn 25
London 25
Seattle 24
Da Nang 23
Stockholm 23
Phoenix 21
Haiphong 20
Rio de Janeiro 20
Ankara 19
Guangzhou 19
Houston 19
Jinan 19
Belo Horizonte 18
Falkenstein 18
Mexico City 18
Atlanta 17
Boston 17
San Francisco 17
Baghdad 16
Mumbai 16
Amsterdam 15
Auburn Hills 15
Council Bluffs 15
Tashkent 15
Washington 15
Manchester 13
Nuremberg 13
Rome 13
Biên Hòa 12
Charlotte 12
Curitiba 12
Istanbul 12
Kunming 12
Nairobi 12
Ningbo 12
Poplar 12
Caracas 11
Lahore 11
Porto Alegre 11
Zhengzhou 11
Buenos Aires 10
Can Tho 10
Hải Dương 10
Totale 12.710
Nome #
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 204
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 198
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 177
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 169
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis 157
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 153
Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. 147
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 146
Biological activity and pathological implications of misfolded proteins. 145
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. 142
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 139
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 138
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 137
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy 137
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 136
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 136
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 134
WALDENSTROM'S HYPERGLOBULINEMIC PURPURA IN HLA IDENTICAL SISTERS. 133
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 133
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 129
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 127
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 127
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 126
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 126
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 125
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 125
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 123
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 123
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 123
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 122
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 122
beta 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation 120
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 120
Biochimica Applicata 119
Capillary electrophoresis investigation of a partially unfolded conformation of Beta 2-microglobulin. 119
AMYLOIDOSIS AL 118
“Separation and quantification of two beta2-microglobulin isoforms”. 118
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 118
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 118
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 117
C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis 116
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 115
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers. 115
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid 115
Amyloid persistence in decellularized liver: Biochemical and histopathological characterization 115
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 115
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 115
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 114
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 113
Cerebrospinal fluid ferritin in human disease. 113
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 113
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 113
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 112
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 111
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 110
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 109
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 109
Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component 108
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 108
USE OF A MONOCLONAL ANTIBODY AGAINST HUMAN HEART FERRITIN FOR EVALUATING ACIDIC FERRITIN CONCENTRATION IN HUMAN SERUM 105
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 105
Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implication 104
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 104
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 104
CHRONIC LYMPHOCYTIC LEUKAEMIA OR IDIOPATHIC COLD HAEMAGGLUTININ DISEASE? A DILEMMA RAISED BY AN ERRONEOUS ELECTRONIC CELL COUNT 102
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 102
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. 101
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. 101
Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- And Long-Distance Conformational Changes 101
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 100
Cinetiche di refolding e studi di affinità mediante elettroforesi capillare: effetto di ligandi di interesse farmaceutico sulla conformazione della Beta 2-microglobulina 100
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 100
Proteomics of beta2-microglobulin amyloid fibrils. 99
Development of a method to screen potential ligands of amyloidogenic proteins 99
DETECTION OF FRAGMENTS OF BETA2-MICROGLOBULIN IN AMYLOID FIBRILS 99
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. 98
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin 97
Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity 97
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 97
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils 97
A Narrative Review of the Role of Transthyretin in Health and Disease 97
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine 97
Conformational transition and cellular toxicity by amyloidogenic proteins 96
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile 96
Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro 95
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 94
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 93
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 93
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 93
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes. 93
An Asp to Asn mutation is a toxic trigger in beta-2 microglobulin: structure and biophysics 93
Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability 93
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 92
Nanobodies against beta2-microglobulin. 92
Bifunctional crosslinking ligands for transthyretin 92
Solution structure of beta(2)-microglobulin and insights into fibrillogenesis 91
Protein Aggregation 91
A CASE OF IgM(KAPPA) MONOCLONAL GAMMOPATHY SIMULATING AN IgM-IgG BICLONAL GAMMOPATHY. 91
AN INTERLEUKIN 2 BINDING FACTOR IN HUMAN SERUM 90
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 90
Totale 11.539
Categoria #
all - tutte 79.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 0 0 0 0 0 0 167 144 32
2021/2022905 15 7 11 13 28 56 18 64 58 36 132 467
2022/20233.045 365 239 26 219 315 280 0 160 1.307 20 64 50
2023/2024968 136 202 40 57 104 222 12 48 8 41 69 29
2024/20252.973 71 240 78 94 76 111 113 222 779 91 336 762
2025/20266.482 536 499 823 782 842 326 1.394 245 602 433 0 0
Totale 19.747